{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T16:17:52Z","timestamp":1782922672801,"version":"3.54.5"},"reference-count":60,"publisher":"BMJ","issue":"1","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Frontline Gastroenterol"],"accepted":{"date-parts":[[2021,2,2]]},"published-print":{"date-parts":[[2022,1]]},"abstract":"<jats:p>Acute severe ulcerative colitis (ASUC) is a medical emergency which is associated with significant morbidity and a mortality rate of 1%. ASUC requires prompt recognition and treatment. Optimal management includes admission to a specialist gastrointestinal unit and joint management with colorectal surgeons. Patients need to be screened for concomitant infections and thromboprophylaxis should be administered to mitigate against the elevated risk of thromboembolism. Corticosteroids are still the preferred initial medical therapy but approximately 30%\u201340% of patients fail steroid therapy and require rescue medical therapy with either infliximab or cyclosporine. Emergency colectomy is required in a timely manner for patients who fail rescue medical therapy to minimise the risk of adverse post-operative outcomes. We discuss current and emerging evidence in the management of ASUC and outline management approaches for clinicians involved in managing ASUC.<\/jats:p>","DOI":"10.1136\/flgastro-2020-101710","type":"journal-article","created":{"date-parts":[[2021,2,18]],"date-time":"2021-02-18T04:30:05Z","timestamp":1613622605000},"page":"64-72","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":8,"title":["How to manage: acute severe colitis"],"prefix":"10.1136","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0604-0770","authenticated-orcid":false,"given":"Thomas Edward","family":"Conley","sequence":"first","affiliation":[{"name":"Gastroenterology, Royal Liverpool and Broadgreen University Hospitals NHS Trust, Liverpool, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0486-2663","authenticated-orcid":false,"given":"Joseph","family":"Fiske","sequence":"additional","affiliation":[{"name":"Gastroenterology, Royal Liverpool and Broadgreen University Hospitals NHS Trust, Liverpool, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2162-3528","authenticated-orcid":false,"given":"Sreedhar","family":"Subramanian","sequence":"additional","affiliation":[{"name":"Gastroenterology, Royal Liverpool and Broadgreen University Hospitals NHS Trust, Liverpool, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2021,2,17]]},"reference":[{"key":"2025090709400015000_13.1.64.1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.2.4947.1041"},{"key":"2025090709400015000_13.1.64.2","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1093\/ecco-jcc\/jjy154","article-title":"Natural disease course of ulcerative colitis during the first five years of follow-up in a European population-based inception Cohort-An Epi-IBD study","volume":"13","author":"Burisch","year":"2019","journal-title":"J Crohns Colitis"},{"key":"2025090709400015000_13.1.64.3","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2011-301978"},{"key":"2025090709400015000_13.1.64.4","first-page":"227","article-title":"Enteral versus parenteral nutrition as adjunct therapy in acute ulcerative colitis","volume":"88","author":"Gonz\u00e1lez-Huix","year":"1993","journal-title":"Am J Gastroenterol"},{"key":"2025090709400015000_13.1.64.5","article-title":"IDDF2020-ABS-0146\u2005Use of antibiotics in ulcerative colitis: systematic review and meta-analysis","volume":"69","author":"Jha","year":"2020","journal-title":"Gut"},{"key":"2025090709400015000_13.1.64.6","doi-asserted-by":"publisher","DOI":"10.1007\/BF02088063"},{"key":"2025090709400015000_13.1.64.7","doi-asserted-by":"crossref","DOI":"10.1038\/ctg.2016.61","article-title":"Early sigmoidoscopy or colonoscopy is associated with improved hospital outcomes in ulcerative Colitis-Related hospitalization","volume":"7","author":"Obi","year":"2016","journal-title":"Clin Transl Gastroenterol"},{"key":"2025090709400015000_13.1.64.8","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2014.01.042"},{"key":"2025090709400015000_13.1.64.9","doi-asserted-by":"publisher","DOI":"10.1136\/gut.34.2.247"},{"key":"2025090709400015000_13.1.64.10","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2019-318484"},{"key":"2025090709400015000_13.1.64.11","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2007.03418.x"},{"key":"2025090709400015000_13.1.64.12","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v19.i43.7577"},{"key":"2025090709400015000_13.1.64.13","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjw117"},{"key":"2025090709400015000_13.1.64.14","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2007.128231"},{"key":"2025090709400015000_13.1.64.15","doi-asserted-by":"publisher","DOI":"10.1016\/j.crohns.2011.09.005"},{"key":"2025090709400015000_13.1.64.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2006.12.028"},{"key":"2025090709400015000_13.1.64.17","doi-asserted-by":"publisher","DOI":"10.14309\/ajg.0000000000000460"},{"key":"2025090709400015000_13.1.64.18","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1097\/MCG.0000000000000769","article-title":"Outcomes with Fidaxomicin therapy in Clostridium difficile infection","volume":"52","author":"Spiceland","year":"2018","journal-title":"J Clin Gastroenterol"},{"key":"2025090709400015000_13.1.64.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.crohns.2013.12.013"},{"key":"2025090709400015000_13.1.64.20","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2013.4"},{"key":"2025090709400015000_13.1.64.21","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1093\/ibd\/izy308","article-title":"Escalation of immunosuppressive therapy for inflammatory bowel disease is not associated with adverse outcomes after infection with Clostridium difficile","volume":"25","author":"Lukin","year":"2019","journal-title":"Inflamm Bowel Dis"},{"key":"2025090709400015000_13.1.64.22","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2014.05.026"},{"key":"2025090709400015000_13.1.64.23","doi-asserted-by":"publisher","DOI":"10.1097\/MIB.0b013e31828075ce"},{"key":"2025090709400015000_13.1.64.24","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1159\/000479865","article-title":"Diagnosis of cytomegalovirus infection during exacerbation of ulcerative colitis","volume":"96","author":"Levin","year":"2017","journal-title":"Digestion"},{"key":"2025090709400015000_13.1.64.25","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1097\/MIB.0000000000001160","article-title":"Impact of infliximab and cyclosporine on the risk of colectomy in hospitalized patients with ulcerative colitis complicated by Cytomegalovirus-A multicenter retrospective study","volume":"23","author":"Kopylov","year":"2017","journal-title":"Inflamm Bowel Dis"},{"key":"2025090709400015000_13.1.64.26","doi-asserted-by":"publisher","DOI":"10.1111\/apt.13124"},{"key":"2025090709400015000_13.1.64.27","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2006.09.033"},{"key":"2025090709400015000_13.1.64.28","doi-asserted-by":"publisher","DOI":"10.1136\/gut.38.6.905"},{"key":"2025090709400015000_13.1.64.29","article-title":"Calcium and vitamin D for corticosteroid-induced osteoporosis","author":"Homik","year":"2000","journal-title":"Cochrane Database Syst Rev"},{"key":"2025090709400015000_13.1.64.30","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)61084-8"},{"key":"2025090709400015000_13.1.64.31","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S2468-1253(16)30003-6","article-title":"Infliximab versus ciclosporin for steroid-resistant acute severe ulcerative colitis (construct): a mixed methods, open-label, pragmatic randomised trial","volume":"1","author":"Williams","year":"2016","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2025090709400015000_13.1.64.32","doi-asserted-by":"crossref","unstructured":"Laharie D , Bourreille A , Branche J . Evolution of endoscopic lesions in Steroid-Refractory acute severe ulcerative colitis responding to infliximab or cyclosporine. Clin Gastroenterol Hepatol 2020;114.doi:10.1016\/j.cgh.2020.08.001","DOI":"10.1016\/j.cgh.2020.08.001"},{"key":"2025090709400015000_13.1.64.33","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.cgh.2018.04.060","article-title":"Safety and efficacy of combination treatment with calcineurin inhibitors and Vedolizumab in patients with refractory inflammatory bowel disease","volume":"17","author":"Christensen","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2025090709400015000_13.1.64.34","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2015.04.016"},{"key":"2025090709400015000_13.1.64.35","doi-asserted-by":"publisher","DOI":"10.1080\/00365520701409035"},{"key":"2025090709400015000_13.1.64.36","doi-asserted-by":"publisher","DOI":"10.5414\/CPP48297"},{"key":"2025090709400015000_13.1.64.37","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1111\/apt.13631","article-title":"Induction infliximab levels among patients with acute severe ulcerative colitis compared with patients with moderately severe ulcerative colitis","volume":"43","author":"Ungar","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"key":"2025090709400015000_13.1.64.38","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2014.07.041"},{"key":"2025090709400015000_13.1.64.39","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1093\/ibd\/izy383","article-title":"Systematic review and meta-analysis: optimal salvage therapy in acute severe ulcerative colitis","volume":"25","author":"Choy","year":"2019","journal-title":"Inflamm Bowel Dis"},{"key":"2025090709400015000_13.1.64.40","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1007\/s10620-018-5407-7","article-title":"Systematic review: efficacy and safety of accelerated induction regimes in infliximab rescue therapy for hospitalized patients with acute severe colitis","volume":"64","author":"Sebastian","year":"2019","journal-title":"Dig Dis Sci"},{"key":"2025090709400015000_13.1.64.41","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1111\/apt.15456","article-title":"Infliximab induction regimens in steroid-refractory acute severe colitis: a multicentre retrospective cohort study with propensity score analysis","volume":"50","author":"Sebastian","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"key":"2025090709400015000_13.1.64.42","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2008.04.035"},{"key":"2025090709400015000_13.1.64.43","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1093\/ecco-jcc\/jjz032","article-title":"Ciclosporin therapy after infliximab failure in hospitalized patients with acute severe colitis is effective and safe","volume":"13","author":"Weisshof","year":"2019","journal-title":"J Crohns Colitis"},{"key":"2025090709400015000_13.1.64.44","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/j.cgh.2018.11.022","article-title":"Efficacy of induction therapy with high-intensity tofacitinib in 4 patients with acute severe ulcerative colitis","volume":"17","author":"Berinstein","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2025090709400015000_13.1.64.45","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1093\/ibd\/izaa157","article-title":"Tofacitinib in acute severe ulcerative Colitis-A real-world tertiary center experience","volume":"26","author":"Honap","year":"2020","journal-title":"Inflamm Bowel Dis"},{"key":"2025090709400015000_13.1.64.46","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1111\/apt.15616","article-title":"Efficacy and safety of induction therapy with calcineurin inhibitors followed by vedolizumab maintenance in 71 patients with severe steroid-refractory ulcerative colitis","volume":"51","author":"Ollech","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"key":"2025090709400015000_13.1.64.47","doi-asserted-by":"publisher","DOI":"10.1016\/j.crohns.2010.02.001"},{"key":"2025090709400015000_13.1.64.48","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2008.119"},{"key":"2025090709400015000_13.1.64.49","article-title":"The ACE (albumin, CRP and endoscopy) index in acute colitis: a simple clinical index on admission that predicts outcome in patients with acute ulcerative colitis","author":"Grant","year":"2020","journal-title":"Inflamm Bowel Dis"},{"key":"2025090709400015000_13.1.64.50","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2004.01945.x"},{"key":"2025090709400015000_13.1.64.51","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1093\/ecco-jcc\/jjx084","article-title":"Faecal calprotectin and UCEIS predict short-term outcomes in acute severe colitis: prospective cohort study","volume":"11","author":"Jain","year":"2017","journal-title":"J Crohns Colitis"},{"key":"2025090709400015000_13.1.64.52","doi-asserted-by":"publisher","DOI":"10.1016\/j.crohns.2010.09.004"},{"key":"2025090709400015000_13.1.64.53","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2007.01653.x"},{"key":"2025090709400015000_13.1.64.54","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjv047"},{"key":"2025090709400015000_13.1.64.55","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1093\/ibd\/izy282","article-title":"Second-Look endoscopy in hospitalized severe ulcerative colitis: a retrospective cohort study","volume":"25","author":"Borren","year":"2019","journal-title":"Inflamm Bowel Dis"},{"key":"2025090709400015000_13.1.64.56","doi-asserted-by":"publisher","DOI":"10.1186\/1471-230X-12-39"},{"key":"2025090709400015000_13.1.64.57","doi-asserted-by":"publisher","DOI":"10.1007\/DCR.0b013e3181975701"},{"key":"2025090709400015000_13.1.64.58","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/SLA.0000000000002275","article-title":"Higher surgical morbidity for ulcerative colitis patients in the era of biologics","volume":"268","author":"Abelson","year":"2018","journal-title":"Ann Surg"},{"key":"2025090709400015000_13.1.64.59","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2008.01.004"},{"key":"2025090709400015000_13.1.64.60","doi-asserted-by":"publisher","DOI":"10.1097\/00042737-199810000-00003"}],"container-title":["Frontline Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/flgastro-2020-101710","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T16:40:10Z","timestamp":1757263210000},"score":1,"resource":{"primary":{"URL":"https:\/\/fg.bmj.com\/lookup\/doi\/10.1136\/flgastro-2020-101710"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,17]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12,7]]},"published-print":{"date-parts":[[2022,1]]}},"alternative-id":["10.1136\/flgastro-2020-101710"],"URL":"https:\/\/doi.org\/10.1136\/flgastro-2020-101710","relation":{},"ISSN":["2041-4137","2041-4145"],"issn-type":[{"value":"2041-4137","type":"print"},{"value":"2041-4145","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,17]]}}}